Page last updated: 2024-09-05

sb 203580 and swertisin

sb 203580 has been researched along with swertisin in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(swertisin)
Trials
(swertisin)
Recent Studies (post-2010) (swertisin)
3,48941,13721019

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhonde, RR; Dadheech, N; Dave, A; Gupta, S; Paranjape, N; Shah, GM; Srivastava, A1

Other Studies

1 other study(ies) available for sb 203580 and swertisin

ArticleYear
Swertisin an Anti-Diabetic Compound Facilitate Islet Neogenesis from Pancreatic Stem/Progenitor Cells via p-38 MAP Kinase-SMAD Pathway: An In-Vitro and In-Vivo Study.
    PloS one, 2015, Volume: 10, Issue:6

    Topics: Animals; Apigenin; Basic Helix-Loop-Helix Transcription Factors; Cell Differentiation; Cells, Cultured; Down-Regulation; Homeodomain Proteins; Humans; Hypoglycemic Agents; Imidazoles; Islets of Langerhans; Male; Mice; Mice, Inbred BALB C; Nerve Tissue Proteins; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Signal Transduction; Smad Proteins; Stem Cells; Trans-Activators; Transcriptional Activation

2015